Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis
A Prospective Randomized Clinical Trial Comparing Menghini-type Needle and Franseen-type Needle for Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Pathological Diagnosis of Sarcoidosis
University Health Network, Toronto
128 participants
Aug 18, 2023
INTERVENTIONAL
Conditions
Summary
This randomized pilot clinical trial aims to examine whether sample collection with Franseen-type needles are effective for the diagnosis of sarcoidosis, as defined by improved sample quality for pathological diagnosis compared to the conventional Menghini-type needle.
Eligibility
Inclusion Criteria3
- Any adult patient aged 18 years or older with enlarged mediastinal and/or hilar lymph nodes
- (≥10 mm short-axis diameter on a CT scan), suspected as having sarcoidosis based on clinical
- history, physical exam, and other investigations, and booked for EBUS-TBNA.
Exclusion Criteria4
- Patients that are unable to provide informed consent
- \- Patients with lymphadenopathy strongly suspected to be secondary to other diseases based on
- clinical history, physical exam, and/or other investigations (e.g., lung cancer, lymphoma,
- infection).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Transbronchial biopsy with Menghini-type or Franseen type Needle
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06220526